Apex Biotechnology Corp.
Apex Biotechnology Corp., a leading name in the biotechnology sector, is headquartered in Taiwan (TW) and operates extensively across Asia and beyond. Founded in 1995, the company has established itself as a pioneer in the development of innovative diagnostic solutions and laboratory equipment, catering to the needs of healthcare professionals and research institutions. Specialising in high-quality reagents, diagnostic kits, and laboratory instruments, Apex Biotechnology stands out for its commitment to precision and reliability. The company has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. With a focus on advancing healthcare through cutting-edge technology, Apex Biotechnology Corp. continues to be a trusted partner in the global biotechnology landscape.
DitchCarbon Score
How does Apex Biotechnology Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Apex Biotechnology Corp.'s score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Apex Biotechnology Corp.'s reported carbon emissions
Apex Biotechnology Corp., headquartered in Taiwan (TW), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As of now, Apex Biotechnology Corp. does not inherit emissions data from any parent or related organizations, nor does it have any commitments to industry-standard initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the biotechnology industry, companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific data or commitments from Apex Biotechnology Corp., it remains unclear how the company plans to address its carbon footprint or contribute to climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Apex Biotechnology Corp. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
